"Simplified carbapenem inactivation method (sCIM) as a reliable tool for detecting OXA-48-producing enterobacterales in clinical practice".

Authors

Ana Collazos-Blanco, Ana Belén García-Sáez, Inés-María Marcos-Palomino, Carolina Plaza-Cristobal, María Isabel Zamora-Cintas, María Simón-Sacristán, García Sáez

Published in

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. Jul 29, 2026. Epub Jul 29, 2026.

Abstract

Carbapenemase-producing Enterobacterales (CPE), particularly OXA-48-producing Enterobacterales, represent a major diagnostic and therapeutic challenge due to their frequent low-level carbapenem resistance and delayed microbiological detection. Rapid confirmation of carbapenemase production is essential to optimize antimicrobial therapy and infection control measures.
This study evaluated the simplified carbapenem inactivation method (sCIM) for detection of OXA-48-producing Enterobacterales. Unlike the conventional mCIM, sCIM eliminates the preliminary carbapenem inactivation incubation step, simplifying the workflow and reducing turnaround time. A total of 150 OXA-48-producing Enterobacterales were analyzed, together with additional VIM-, KPC-producing, and non-carbapenemase-producing isolates collected from clinical specimens at the Hospital Central de la Defensa "Gómez-Ulla" in Spain. Carbapenemase production was confirmed using the Xpert^® Carba-R molecular assay.
The sCIM detected all OXA-48-producing Enterobacterales with 100% sensitivity (95% CI: 97.6-100%) and no indeterminate results, including isolates with low ertapenem MICs. Results were available after 16-18 h of incubation without previous 4-hour carbapenem inactivation step, simplifying laboratory workflow compared with the conventional mCIM.
The rapid detection of OXA-48-producing Enterobacterales remains a major diagnostic challenge due to their frequently low carbapenem MICs and subtle phenotypic expression. This study demonstrates that sCIM provides a simple, reliable, and highly sensitive method for detecting these isolates, even in cases with borderline susceptibility profiles. Given its low cost and ease of implementation, sCIM represents a valuable tool for routine clinical laboratories, particularly in high-prevalence or resource-limited settings.

PMID:
42525316
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.